These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23189822)

  • 1. [Molecular evolution of physiologically functioning anti-retroviral APOBEC3 deaminases].
    Miyazawa M
    Uirusu; 2012 Jun; 62(1):27-38. PubMed ID: 23189822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteins.
    Perez-Caballero D; Soll SJ; Bieniasz PD
    PLoS Pathog; 2008 Oct; 4(10):e1000181. PubMed ID: 18927623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.
    Nakano Y; Aso H; Soper A; Yamada E; Moriwaki M; Juarez-Fernandez G; Koyanagi Y; Sato K
    Retrovirology; 2017 May; 14(1):31. PubMed ID: 28482907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restriction by APOBEC3 proteins of endogenous retroviruses with an extracellular life cycle: ex vivo effects and in vivo "traces" on the murine IAPE and human HERV-K elements.
    Esnault C; Priet S; Ribet D; Heidmann O; Heidmann T
    Retrovirology; 2008 Aug; 5():75. PubMed ID: 18702815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse APOBEC3 Restriction of Retroviruses.
    Salas-Briceno K; Zhao W; Ross SR
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33121095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the Complicated Scenario of Primate APOBEC3 Gene Evolution.
    Uriu K; Kosugi Y; Suzuki N; Ito J; Sato K
    J Virol; 2021 May; 95(12):. PubMed ID: 33789992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction of feline retroviruses: lessons from cat APOBEC3 cytidine deaminases and TRIM5alpha proteins.
    Münk C; Hechler T; Chareza S; Löchelt M
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):14-24. PubMed ID: 19896724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Battle between Retroviruses and APOBEC3 Genes: Its Past and Present.
    Uriu K; Kosugi Y; Ito J; Sato K
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC3-mediated restriction of RNA virus replication.
    Milewska A; Kindler E; Vkovski P; Zeglen S; Ochman M; Thiel V; Rajfur Z; Pyrc K
    Sci Rep; 2018 Apr; 8(1):5960. PubMed ID: 29654310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human APOBEC3 Variations and Viral Infection.
    Sadeghpour S; Khodaee S; Rahnama M; Rahimi H; Ebrahimi D
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deaminase-Dead Mouse APOBEC3 Is an
    Stavrou S; Zhao W; Blouch K; Ross SR
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.
    Hakata Y; Landau NR
    J Biol Chem; 2006 Dec; 281(48):36624-31. PubMed ID: 17020885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.
    OhAinle M; Kerns JA; Malik HS; Emerman M
    J Virol; 2006 Apr; 80(8):3853-62. PubMed ID: 16571802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms for inhibition of retrovirus replication by APOBEC3 family].
    Iwatani Y
    Uirusu; 2011 Jun; 61(1):67-72. PubMed ID: 21972557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations.
    Duggal NK; Fu W; Akey JM; Emerman M
    Virology; 2013 Sep; 443(2):329-37. PubMed ID: 23755966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviruses under editing crossfire: a second member of the human APOBEC3 family is a Vif-blockable innate antiretroviral factor.
    Trono D
    EMBO Rep; 2004 Jul; 5(7):679-80. PubMed ID: 15229643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins.
    Rosales Gerpe MC; Renner TM; Bélanger K; Lam C; Aydin H; Langlois MA
    J Virol; 2015 Feb; 89(4):2342-57. PubMed ID: 25505062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle.
    Chiu YL; Greene WC
    J Biol Chem; 2006 Mar; 281(13):8309-12. PubMed ID: 16407183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.
    Takeda E; Tsuji-Kawahara S; Sakamoto M; Langlois MA; Neuberger MS; Rada C; Miyazawa M
    J Virol; 2008 Nov; 82(22):10998-1008. PubMed ID: 18786991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.
    Zielonka J; Bravo IG; Marino D; Conrad E; Perković M; Battenberg M; Cichutek K; Münk C
    J Virol; 2009 Aug; 83(15):7547-59. PubMed ID: 19458006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.